Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre, Observational, Non-comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Eurosilicone LunaXT Range of Silicone Breast Implants When Used in Breast Implantation.

NCT07679594 is registered in ClinicalTrials.gov with GCA (Eurosilicone) as lead sponsor.

NCT NCT07679594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07679594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre, Observational, Non-comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Eurosilicone LunaXT Range of Silicone Breast Implants When Used in Breast Implantation.
Lead sponsor
GCA (Eurosilicone)
Phase
Observational
Overall status
Recruiting
Start date
March 30, 2026
Completion date
December 31, 2038
Enrollment
650 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast augmentation, breast augmentation and breast reconstruction, breast reconstruction, breast reconstruction with silicone implants, breast reconstruction, revision breast reconstruction, breast revision-augmentation